Shenzhen Hepalink Pharmac... (SHEZF)

PNK: SHEZF · Real-Time Price · USD

0.47

0.00 (0.09%)

At close: Apr 30, 2025, 8:00 PM

Shenzhen Hepalink Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	5.28B	5.45B	7.16B	6.37B	5.33B	4.62B	4.81B	2.67B	2.26B
Cost of Revenue	3.52B	4.5B	4.83B	4.33B	3.24B	2.9B	2.88B	2.03B	1.54B
Gross Profit	1.76B	944.92M	2.33B	2.03B	2.09B	1.73B	1.93B	640.01M	723.34M
Operating Income	741.31M	-860.91M	828.62M	227.47M	1.33B	1.31B	721.15M	-7.4M	435.61M
Interest Income	44.37M	24.04M	54.14M	54.86M	34.65M	45.67M	69.46M	137.83M	132.25M
Pretax Income	726.23M	-928.33M	829.85M	222.26M	1.33B	1.31B	730.85M	4.5M	474.94M
Net Income	646.74M	-783.26M	727.43M	240.79M	1.02B	1.06B	616.19M	131.33M	396.89M
Selling & General & Admin	454.67M	590.13M	665M	572.83M	559.67M	539.65M	416.27M	182.73M	178.91M
Research & Development	212.04M	184.66M	252.14M	221.1M	160.01M	148.71M	186.85M	79.63M	62.05M
Other Expenses	348.13M	1.03B	-101.25M	42.91M	504.82M	199.93M	9.7M	11.91M	40M
Operating Expenses	1.01B	1.81B	1.21B	1.07B	960.98M	896.5M	845.39M	450.61M	457.11M
Interest Expense	141.18M	223.22M	235.24M	201.63M	247.72M	257.8M	199.53M	137.36M	79.8M
Selling & Marketing Expenses	309.36M	445.49M	518.5M	430.49M	408.9M	411.32M	290.27M	63.58M	42.17M
Cost & Expenses	4.54B	6.31B	6.04B	5.4B	4.21B	3.8B	3.73B	2.48B	1.99B
Income Tax Expense	101.31M	-126.17M	115.16M	-11.12M	306.2M	271.38M	138.66M	-113.68M	88.82M
Shares Outstanding (Basic)	1.47B	1.47B	1.47B	1.47B	1.35B	1.25B	1.25B	1.25B	1.25B
Shares Outstanding (Diluted)	1.47B	1.47B	1.47B	1.47B	1.35B	1.25B	1.25B	1.25B	1.25B
EPS (Basic)	0.44	-0.53	0.50	0.16	0.76	0.85	0.49	0.11	0.32
EPS (Diluted)	0.44	-0.53	0.50	0.16	0.76	0.85	0.49	0.11	0.32
EBITDA	1.2B	-331.52M	1.37B	726.64M	1.88B	1.83B	1.12B	348.64M	391.82M
EBIT	867.41M	-705.11M	1.07B	423.89M	1.58B	1.57B	901.72M	241.55M	554.74M
Depreciation & Amortization	331.05M	384.67M	318.2M	307.38M	307.47M	259.35M	227.43M	195.7M	170.8M